To the editor

New England Journal of Medicine

Volumn 371, Issue 10, 2014, Pages 966-

  Bestetti, Reinaldo B ^a   Restini, Carolina B A ^a  

^a UNIVERSITY OF RIBEIRÃO PRETO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BENZNIDAZOLE; POSACONAZOLE; ANTITRYPANOSOMAL AGENT; NITROIMIDAZOLE DERIVATIVE; TRIAZOLE DERIVATIVE;

CHAGAS DISEASE; DNA DETERMINATION; DRUG USE; HUMAN; LETTER; PATIENT CARE; REAL TIME POLYMERASE CHAIN REACTION; SEROLOGY; TREATMENT FAILURE; TREATMENT INDICATION; TRYPANOSOMA CRUZI; FEMALE; MALE; NOTE;

CHAGAS DISEASE; FEMALE; HUMANS; MALE; NITROIMIDAZOLES; TRIAZOLES; TRYPANOCIDAL AGENTS;

EID: 84908236023     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1407914     Document Type: Letter

References (4)

1. Bestetti RB. Should benznidazole be used in chronic Chagas' disease? Lancet 1997;349:653.
2. Bern C. Antitrypanosomal therapy for chronic Chagas' disease. N Engl J Med 2011;364:2527-34.
3. Bestetti RB, Cardinalli-Neto A. Antitrypanosomal therapy for chronic Chagas' disease. N Engl J Med 2011;365:1258-9.
4. Andrade JP, Marin-Neto JA, Paola AAV, et al. I Diretriz Latino-Americana para o diagnóstico e tratamento da cardiopatia Chagásica. Arq Bras Cardiol 2011;97:Suppl:1-48.